Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 4
2004 7
2005 6
2006 6
2007 7
2008 4
2009 5
2010 10
2011 13
2012 7
2013 8
2014 7
2015 12
2016 7
2017 11
2018 7
2019 8
2020 6
2021 1
2022 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
The Mediterranean diet.
Morris L, Bhatnagar D. Morris L, et al. Among authors: bhatnagar d. Curr Opin Lipidol. 2016 Feb;27(1):89-91. doi: 10.1097/MOL.0000000000000266. Curr Opin Lipidol. 2016. PMID: 26655296 No abstract available.
Yoga-Based Cardiac Rehabilitation After Acute Myocardial Infarction: A Randomized Trial.
Prabhakaran D, Chandrasekaran AM, Singh K, Mohan B, Chattopadhyay K, Chadha DS, Negi PC, Bhat P, Sadananda KS, Ajay VS, Singh K, Praveen PA, Devarajan R, Kondal D, Soni D, Mallinson P, Manchanda SC, Madan K, Hughes AD, Chathurvedi N, Roberts I, Ebrahim S, Reddy KS, Tandon N, Pocock S, Roy A, Kinra S; Yoga-CaRe Trial Investigators. Prabhakaran D, et al. J Am Coll Cardiol. 2020 Apr 7;75(13):1551-1561. doi: 10.1016/j.jacc.2020.01.050. J Am Coll Cardiol. 2020. PMID: 32241371 Free PMC article. Clinical Trial.
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC; ELIXA Investigators. Pfeffer MA, et al. N Engl J Med. 2015 Dec 3;373(23):2247-57. doi: 10.1056/NEJMoa1509225. N Engl J Med. 2015. PMID: 26630143 Free article. Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Lipoprotein (a) in familial hypercholesterolaemia.
Durrington PN, Bashir B, Bhatnagar D, Soran H. Durrington PN, et al. Among authors: bhatnagar d. Curr Opin Lipidol. 2022 Aug 1;33(4):257-263. doi: 10.1097/MOL.0000000000000839. Curr Opin Lipidol. 2022. PMID: 35942820 Review.
Nutrition and its impact on cardiovascular disease.
Bhatnagar D, Bhatnagar P. Bhatnagar D, et al. Curr Opin Lipidol. 2022 Jun 1;33(3):211-212. doi: 10.1097/MOL.0000000000000816. Curr Opin Lipidol. 2022. PMID: 35695618 No abstract available.
Modulation of cardiovascular risk factors.
Bhatnagar D, Shiraz A. Bhatnagar D, et al. Curr Opin Lipidol. 2018 Jun;29(3):269-270. doi: 10.1097/MOL.0000000000000516. Curr Opin Lipidol. 2018. PMID: 29715242 No abstract available.
Dietary adherence and cardiovascular risk.
Bhatnagar D. Bhatnagar D. Curr Opin Lipidol. 2017 Apr;28(2):214-215. doi: 10.1097/MOL.0000000000000406. Curr Opin Lipidol. 2017. PMID: 28169871 No abstract available.
Interaction between carbohydrates and lipid metabolism.
Kulavarasalingam K, Bhatnagar D. Kulavarasalingam K, et al. Among authors: bhatnagar d. Curr Opin Lipidol. 2014 Oct;25(5):401-3. doi: 10.1097/MOL.0000000000000117. Curr Opin Lipidol. 2014. PMID: 25186200 Review. No abstract available.
133 results